This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:

GSK Highlights P-III (DREAMM-8) Study Data of Blenrep Plus Pomalidomide and Dexamethasone for R/R Multiple Myeloma at ASCO 2024

Read More: GSK                                                                                                           

Eli Lilly Highlights the P-I/II Trial Data of Olomorasib for Treating Advanced Solid Tumors at ASCO 2024

Read More: Eli Lilly                                                                                                    

Pfizer Reports the P-III (ECHELON-3) Trial Results of Adcetris for Treating R/R Diffuse Large B-cell Lymphoma (DLBCL)

Read More: Pfizer                                                                                                          

Sanofi Highlights the P-III (IMROZ) Study Data of Sarclisa for Newly Diagnosed Transplant-Ineligible Multiple Myeloma

Read More: Sanofi                                                                                                    

BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024

Read More: BMS                                                                                                           

BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 2024

Read More: BMS                                                                                                            

The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Multiple Solid Tumors

Read More: MediciNova                                                                                             

Gilead Reports Data from the P-III (ASSURE) Trial of Seladelpar for Treating Primary Biliary Cholangitis

Read More: Gilead                                                                                                        

AbbVie Reports Advancement of ABBV-383 to P-III Study for the Treatment of Multiple Myeloma

Read More: AbbVie                                                                                                  

Amgen Reports the P-III (MITIGATE) Study Data of Uplizna (Inebilizumab-cdon) to Treat Immunoglobulin G4-Related Disease (IgG4-RD)

Read More: Amgen                                                                                                       

AbbVie Reports the P-II (PICCOLO) Study Data of Elahere (Mirvetuximab Soravtansine) for Treating Ovarian Cancer

Read More: AbbVie                                                                                                       

Boehringer Ingelheim Reports Additional Data from the P-II Study of Survodutide to Treat Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read More: Boehringer Ingelheim                                                                            

AstraZeneca’s Tagrisso Receives the CHMP’s Positive Opinion for Treating EGFR-Mutated advanced Lung Cancer

Read More: AstraZeneca                                                                                              

CStone Pharmaceuticals’ Cejemly Receives the CHMP’s Positive Opinion for Treating NSCLC

Read More: CStone Pharmaceuticals                                                                         

NeoImmuneTech’s Efineptakin Alfa (NT-I7) Receives the EMA’s Orphan Drug Designation to Treat Acute Radiation Syndrome

Read More: NeoImmuneTech                                                                                    

Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

Read More: Saghmos Therapeutics                                                                           

Geron’s Rytelo (Imetelstat) Gains the US FDA’s Approval to Treat Myelodysplastic Syndromes (MDS) with Transfusion-Dependent Anemia

Read More: Geron                                                                                                         

Immutep Partners with Merck to Conduct P-III Study of Eftilagimod Alfa (Efti) with Keytruda for Treating NSCLC

Read More: Immutep & Merck                                                                                 

FibroGen Collaborates with Regeneron to Assess FG-3165 and FG-3175 Plus Libtayo for Treating Solid Tumors

Read More: FibroGen & Regeneron                                                                          

BlueSphere Bio and the National Cancer Institute Team Up to Develop Therapies for Rare Respiratory Disease

Read More: BlueSphere Bio & National Cancer Institute                                    

ArriVent BioPharma Collaborates with Alphamab to Develop Antibody Drug Conjugates for Treating Cancers

Read More: ArriVent BioPharma & Alphamab                                                     

HighLife’s TSMVR System Obtains the US FDA’s IDE Approval to Commence Clinical Trial for Treating Mitral Regurgitation

Read More: HighLife                                                                                                       

Evolution Optiks Gains the US FDA’s 510(k) Clearance for Eye Examination Device

Read More: Evolution Optiks                                                                                      

The US FDA Grants Clearance to Moon Surgical’s Commercial Maestro Robotic Surgery System

Read More: Moon Surgical                                                                                         

Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

Read More: Abbott                                                                                                      

Stryker Acquires Artelon, Enhancing its Portfolio of Soft Tissue Fixation Solutions

Read More: Stryker & Artelon                                                                                     

BD Reports the Acquisition of Edwards Lifesciences' Critical Care Product Group, Enhancing its Smart Connected Care Solutions

Read More: BD & Edwards Lifesciences                                                                 

GSK Acquires Elsie Biotechnologies to Advance Oligonucleotide Platform and Pipeline Therapies

Read More: GSK & Elsie Biotechnologies                                                               

Ventyx Biosciences Reports Preclinical Data of VTX3232 in Murine Diet-Induced Obesity Models

Read More: Ventyx Biosciences                                                                              

Zomedica Highlights the Data of TRUFORMA Research to Diagnose Thyroid Disease in Cats at ACVIM 2024

Read More: Zomedica               

Related Post: PharmaShots Weekly Snapshots (May 27 – May 31, 2024)